While platelet activation has long been recognized in women with breast cancer [37] and higher levels of VEGF are sequestered in platelets of breast cancer cases compared to healthy women [43], it is not known to what extent serum levels of VEGF capture non-tumor vs tumor-derived sources of this marker. The gene discussed is VEGFA; the disease is breast carcinoma.